Companies / Cero Therapeutics Holdings, Inc.
Cero Therapeutics Holdings, Inc.
OTC: CEROCIK 1870404SOUTH SAN FRANCISCO, CA
Financials
Ownership
45.1M shares outstanding · as of May 14, 2026
Ownership
| 10%+ / strategic | 4.06% | 1,830,007 |
| Institutions | 0.00% | 3 |
| Public float | 95.94% | 43,282,396 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 8
View all →| Insider | % of shares | Shares |
|---|---|---|
Atwood Brian GDirector | — | — |
Byrnes MichaelDirector | — | — |
Ehrlich Christopher BCEOChairman and CEO · Director | — | — |
Kucharchuk Andrew AlbertFormerChief Financial Officer | — | — |
Laporte KathleenDirector | — | — |
Patel ShamiDirector | — | — |
Pierce KristenChief Development Officer | — | — |
Rolfe LindseyDirector | — | — |
Institutional holders 1
View all →| Holder | Value | % of shares |
|---|---|---|
| $15 | <0.01% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | Pierce Kristen Executive | Grant | Stock Option (Right to Buy) | — | +1.6M | 1,612,099 3.57% of shares | low |
| Jan 7, 2026 | Kucharchuk Andrew Albert Executive | Grant | Stock Option (Right to Buy) | — | +1.2M | 1,162,099 2.58% of shares | low |
| Jan 7, 2026 | Rolfe Lindsey Director | Grant | Stock Option (Right to Buy) | — | +691K | 690,900 1.53% of shares | low |
| Jan 7, 2026 | Byrnes Michael Director | Grant | Stock Option (Right to Buy) | — | +691K | 690,900 1.53% of shares | low |
| Jan 7, 2026 | Patel Shami Director | Grant | Stock Option (Right to Buy) | — | +691K | 690,900 1.53% of shares | low |
| Jan 7, 2026 | Ehrlich Christopher B CEO | Grant | Stock Option (Right to Buy) | — | +4.5M | 4,530,997 10.04% of shares | low |
| Jan 7, 2026 | Atwood Brian G Director | Grant | Stock Option (Right to Buy) | — | +1.6M | 1,612,099 3.57% of shares | low |
| Jan 7, 2026 | Laporte Kathleen Director | Grant | Stock Option (Right to Buy) | — | +691K | 690,900 1.53% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Tibbs Isaiah | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| CERO | Common Stock | 71902K402 |